The Peptide Directory

Not approved (research only)Research blendGrowth hormone research

Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend

This vendor blend combines tesamorelin, CJC-1295 (no DAC) and ipamorelin in one vial; the combination has not been studied as a product.

Last reviewed by The Peptide Directory Editorial Team

What is Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend?

This vendor blend combines tesamorelin, CJC-1295 (no DAC) and ipamorelin in one vial; the combination has not been studied as a product. Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.

Key takeaways

  1. Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.
  2. PubMed indexes 95 papers on Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend (23 tagged as clinical trials) as of October 19, 2026.
  3. No vendor in our directory listed Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend when we checked.

What is in this blend?

The blend combines 3 compounds. No published study has tested this combination as a product; each component's evidence is separate.

Regulatory & access status

Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.

Sellers that market unapproved peptides for human use can receive FDA warning letters; our vendor directory links any letter we found on fda.gov.

How much research exists on Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend?

PubMed indexes 95 papers mentioning Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend in the title or abstract, 34 of them from the last five years and 23 tagged as clinical trials (search run October 19, 2026; repeat the search).

Most relevant recent papers

What the evidence does not show

  • Paper counts measure research attention, not whether Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend works or is safe.
  • No FDA review of any "research use only" product's identity, purity, sterility or dose.
  • No study of this specific blend as sold.

Research suppliers that list Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend

None of the vendors in our directory listed Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend in their public catalog when we checked. The vendor directory records what each vendor publishes about testing.

Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend reconstitution math

Lab arithmetic only, not dosing guidance: use the peptide calculator to turn a vial size and diluent volume into a concentration.

Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend FAQ

Is Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend FDA-approved?

Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend is not approved by the FDA for any use; products sold under this name are labeled for research use only, not for human consumption.

Is Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend safe?

Safety data come from the published studies listed on this page; read them in full. Products sold as "research use only" have no FDA review of their purity, sterility or dose.

How much research is there on Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend?

PubMed indexes 95 papers on Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend (23 tagged as clinical trials) as of October 19, 2026.

Who sells Tesamorelin + CJC-1295 (no DAC) + ipamorelin blend?

None of the vendors in our directory listed it when we checked.

Related compounds

Follistatin-315FollistatinGHRHGHRP-6SomatropinHexarelinBPC-157 + TB-500 blendTri-heal blendAll growth hormone & ghrhAll blends & stacks